SGMT - Sagimet Biosciences Series A Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SGMT is currently covered by 2 analysts with an average price target of $23.06. This is a potential upside of $15.71 (213.74%) from yesterday's end of day stock price of $7.35.

Sagimet Biosciences Series A Common Stock's activity chart (see below) currently has 2 price targets and 11 ratings on display. The stock rating distribution of SGMT is 88.89% BUY and 11.11% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 64 days.

Highest price target for SGMT is $18, Lowest price target is $3, average price target is $6.

Most recent stock forecast was given by JONATHAN WOLLEBEN from JMP on 15-Aug-2024. First documented stock forecast 08-Aug-2023.

Best performing analysts who are covering SGMT - Sagimet Biosciences Series A Common Stock:

Jonathan Wolleben Andrea Tan

Currently out of the existing stock ratings of SGMT, 8 are a BUY (88.89%), 1 are a HOLD (11.11%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

1 years 6 days ago
(15-Aug-2024)

0/2 (0%)

$28.58 (155.16%)

Hold

$6

$-1.67 (-21.77%)

$23

1 years 1 months 20 days ago
(01-Jul-2024)

1/4 (25%)

$2.84 (89.87%)

128

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SGMT (Sagimet Biosciences Series A Common Stock) average time for price targets to be met?

On average it took 64 days on average for the stock forecasts to be realized with a an average price target met ratio 12.5

Which analyst has the current highest performing score on SGMT (Sagimet Biosciences Series A Common Stock) with a proven track record?

JONATHAN WOLLEBEN

Which analyst has the current lower performing score on SGMT (Sagimet Biosciences Series A Common Stock) with a proven track record?

ANDREA TAN

Which analyst has the most public recommendations on SGMT (Sagimet Biosciences Series A Common Stock)?

Jonathan Wolleben works at JMP and has 10 price targets and 10 ratings on SGMT

Which analyst is the currently most bullish on SGMT (Sagimet Biosciences Series A Common Stock)?

Jonathan Wolleben with highest potential upside - $0

Which analyst is the currently most reserved on SGMT (Sagimet Biosciences Series A Common Stock)?

Andrea Tan with lowest potential downside - -$1.67

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?